Examining Racial Genomics in Prostate Cancer
August 8th 2020Although the genomic profiles of African American men with prostate cancer differ from those of European American men, new data show that the frequency of actionable mutations for which targeted therapies exist occurs at a comparable rate in both populations.
ctDNA Identifies Adjuvant MRD Positivity, Relapse in Lung Cancer
May 2nd 2020Results from the Lung TRACERx study, in which the biomarker was found, has the potential to set the stage for future clinical trials that are structured to increase the standard-of-care dosage in patients with non–small cell lung cancer (NSCLC) who become MRD-positive after surgery.